• 940 Citations
  • 17 Scopus h-Index
20052019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2005 2019

Filter
Article
Article
10 Citations (Scopus)

Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: A SEER-medicare analysis

Ailawadhi, S., Frank, R. D., Advani, P., Swaika, A., Temkit, M., Menghani, R., Sharma, M., Meghji, Z., Paulus, S., Khera, N. D., Hashmi, S. K., Paulus, A., Kakar, T. S., Hodge, D. O., Colibaseanu, D. T., Vizzini, M. R., Roy, V., Colon-Otero, G. & Chanan Khan, A. A., 2017, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

Medicare
Multiple Myeloma
Stem Cells
Thalidomide
Transplants
28 Citations (Scopus)

Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib

Kumar, S. K., LaPlant, B. R., Reeder, C. B., Roy, V., Halvorson, A. E., Buadi, F., Gertz, M., Bergsagel, P. L., Dispenzieri, A., Thompson, M. A., Crawley, J., Kapoor, P., Mikhael, J. R., Stewart, A. K., Hayman, S. R., Hwa, Y. L., Gonsalves, W., Witzig, T. E., Ailawadhi, S., Dingli, D. M. & 5 others, Go, R. S., Lin, Y., Rivera, C. E., Rajkumar, S. V. & Lacy, M., Nov 17 2016, In : Blood. 128, 20, p. 2415-2422 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Refractory materials
Dexamethasone
Toxicity
Proteasome Inhibitors
6 Citations (Scopus)

Re: FDG PET/CT Findings of Intracardiac Myeloid Sarcoma

Sahu, K. K., Gautam, A. & Ailawadhi, S., Nov 4 2016, (Accepted/In press) In : Clinical Nuclear Medicine.

Research output: Contribution to journalArticle

Myeloid Sarcoma
7 Citations (Scopus)

Reactivation of Chagas disease in a bone marrow transplant patient: Case report and review of screening and management

Guiang, K. M. U., Cantey, P., Montgomery, S. P., Ailawadhi, S., Qvarnstrom, Y., Price, T. & Blodget, E., Dec 2013, In : Transplant Infectious Disease. 15, 6

Research output: Contribution to journalArticle

Chagas Disease
Bone Marrow
Transplants
Transplantation
Stem Cells
3 Citations (Scopus)

Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant

Dholaria, B., Patel, R. J., Sluzevich, J. C., Ailawadhi, S. & Roy, V., Sep 6 2017, (Accepted/In press) In : Annals of Hematology. p. 1-2 2 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cells
Transplants
Subcutaneous panniculitis-like T-cell lymphoma
1 Citation (Scopus)

Representation of Minorities and Elderly Patients in Multiple Myeloma Clinical Trials

Duma, N., Azam, T., Riaz, I. B., Gonzalez-Velez, M., Ailawadhi, S. & Go, R., Jan 1 2018, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Multiple Myeloma
Clinical Trials
Hispanic Americans
Ethnic Groups
Research Personnel
2 Citations (Scopus)

Role of Proteasome Inhibitors in Relapsed and/or Refractory Multiple Myeloma

Leleu, X., Martin, T. G., Einsele, H., Lyons, R. M., Durie, B. G. M., Iskander, K. S. & Ailawadhi, S., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Proteasome Inhibitors
Multiple Myeloma
Therapeutics
Proteasome Endopeptidase Complex
Plasma Cells
1 Citation (Scopus)

Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatment

Vidisheva, A. P., Wang, J., Spektor, T. M., Bitran, J. D., Lutzky, J., Tabbara, I. A., Ye, J. Z., Ailawadhi, S., Stampleman, L. V., Steis, R. G., Moezi, M. M., Swift, R. A., Maluso, T. M., Udd, K. A., Eshaghian, S., Nassir, Y. & Berenson, J. R., Apr 28 2017, (Accepted/In press) In : Supportive Care in Cancer. p. 1-8 8 p.

Research output: Contribution to journalArticle

Retreatment
Peripheral Nervous System Diseases
Safety
Therapeutics
Bortezomib
9 Citations (Scopus)

Second primary acute lymphoblastic leukemia in adults: A SEER analysis of incidence and outcomes

Swaika, A., Frank, R. D., Yang, D., Finn, L. E., Jiang, L., Advani, P., Chanan Khan, A. A., Ailawadhi, S. & Foran, J. M., Jan 1 2017, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Epidemiology
Incidence
Survival
Prostate
46 Citations (Scopus)

Serotonin syndrome caused by interaction between citalopram and fentanyl

Ailawadhi, S., Sung, K. W., Carlson, L. A. & Baer, M. R., Apr 2007, In : Journal of Clinical Pharmacy and Therapeutics. 32, 2, p. 199-202 4 p.

Research output: Contribution to journalArticle

Serotonin Syndrome
Citalopram
Fentanyl
Neurologic Gait Disorders
Pain
3 Citations (Scopus)

Survival trends among non-small-cell lung cancer patients over a decade: impact of initial therapy at academic centers

Lou, Y., Dholaria, B., Soyano, A., Hodge, D., Cochuyt, J., Manochakian, R., Ko, S. J., Thomas, M., Johnson, M., Patel, N. M., Miller, R. C., Adjei, A. & Ailawadhi, S., Jan 1 2018, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Survival
Therapeutics
Databases
Neoplasms

Survival trends in glioblastoma and association with treating facility volume

Aulakh, S., DeDeo, M. R., Free, J., Rosenfeld, S., Quinones-Hinojosa, A., Paulus, A., Manna, A., Manochakian, R., Chanan Khan, A. A. & Ailawadhi, S., Jan 1 2019, In : Journal of Clinical Neuroscience.

Research output: Contribution to journalArticle

Glioblastoma
temozolomide
Survival
Therapeutics
Neoplasms

Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities

Ailawadhi, S., Azzouqa, A. G., Hodge, D., Cochuyt, J., Jani, P., Ahmed, S., Sher, T., Roy, V., Ailawadhi, M., Alegria, V. R., Manochakian, R., Vishnu, P., Grover, A., Abdulazeez, M. F., Paulus, A. & Chanan Khan, A. A., Jan 1 2019, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Survival
Survival Rate
Hispanic Americans
Epidemiology
28 Citations (Scopus)
Waldenstrom Macroglobulinemia
Apoptosis
Proteasome Endopeptidase Complex
Neoplasms
Ubiquitinated Proteins
1 Citation (Scopus)

Targeting CD38 enhances the antileukemic activity of ibrutinib in chronic lymphocytic leukemia

Manna, A., Aulakh, S., Jani, P., Ahmed, S., Akhtar, S., Coignet, M., Heckman, M., Meghji, Z., Bhatia, K., Sharma, A., Sher, T., Alegria, V., Malavasi, F., Chini, E. N., Chanan Khan, A. A., Ailawadhi, S. & Paulus, A., Jan 1 2019, In : Clinical Cancer Research. 25, 13, p. 3974-3985 12 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Heterografts
B-Lymphocytes
Antibody-Dependent Cell Cytotoxicity
PCI 32765
1 Citation (Scopus)

Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells

Paulus, A., Manna, A., Akhtar, S., Paulus, S. M., Sharma, M., Coignet, M. V., Jiang, L., Roy, V., Witzig, T. E., Ansell, S. M., Allan, J., Furman, R., Aulakh, S., Manochakian, R., Ailawadhi, S., Chanan Khan, A. A. & Sher, T., Jan 1 2018, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Cytophagocytosis
Antibodies
B-Lymphocytes
Cell Death
3 Citations (Scopus)

The Determinants of Palliative Care Use in Patients With Colorectal Cancer: A National Study

Colibaseanu, D. T., Osagiede, O., Spaulding, A., Frank, R. D., Merchea, A., Mathis, K. L., Parker, A. & Ailawadhi, S., Jan 1 2018, (Accepted/In press) In : American Journal of Hospice and Palliative Medicine.

Research output: Contribution to journalArticle

Palliative Care
Colorectal Neoplasms
Insurance Coverage
Survival
Logistic Models
34 Citations (Scopus)

Treatment-free remission after second-line nilotinib treatment in patients with chronic myeloid leukemia in chronic phase results from a single-group, phase 2, open-label study

Mahon, F. X., Boquimpani, C., Kim, D. W., Benyamini, N., Clementino, N. C. D., Shuvaev, V., Ailawadhi, S., Lipton, J. H., Turkina, A. G., De Paz, R., Moiraghi, B., Nicolini, F. E., Dengler, J., Sacha, T., Takahashi, N., Fellague-Chebra, R., Acharya, S., Wong, S., Jin, Y. & Hughes, T. P., Apr 3 2018, In : Annals of Internal Medicine. 168, 7, p. 461-470 10 p.

Research output: Contribution to journalArticle

Leukemia, Myeloid, Chronic Phase
Therapeutics
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
55 Citations (Scopus)

Treatment of Immunoglobulin Light Chain Amyloidosis Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement

Dispenzieri, A., Buadi, F., Kumar, S. K., Reeder, C. B., Sher, T., Lacy, M., Kyle, R. A., Mikhael, J. R., Roy, V., Leung, N., Grogan, M., Kapoor, P., Lust, J. A., Dingli, D. M., Go, R. S., Hwa, Y. L., Hayman, S. R., Fonseca, R., Ailawadhi, S., Bergsagel, P. L. & 6 others, Chanan Khan, A. A., Rajkumar, S. V., Russell, S. J., Stewart, A. K., Zeldenrust, S. R. & Gertz, M., Aug 1 2015, In : Mayo Clinic Proceedings. 90, 8, p. 1054-1081 28 p.

Research output: Contribution to journalArticle

Immunoglobulin Light Chains
Amyloidosis
Consensus
Expert Testimony
Therapeutics
3 Citations (Scopus)

Treatment options for multiple myeloma patients with high-risk disease

Ailawadhi, S., Masood, A., Sher, T., Miller, K. C., Wood, M., Lee, K. & Chanan Khan, A. A., Jun 2010, In : Medical Oncology. 27, SUPPL. 1

Research output: Contribution to journalArticle

Multiple Myeloma
Cytogenetics
Therapeutics
Biological Factors
Clinical Trials
8 Citations (Scopus)

Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities

Ailawadhi, S., Frank, R. D., Sharma, M., Menghani, R., Temkit, M., Paulus, S., Khera, N. D., Hashmi, S., Advani, P., Swaika, A., Paulus, A., Aslam, N., Sher, T., Roy, V., Colon-Otero, G. & Chanan Khan, A. A., Jan 1 2018, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Medicare
Multiple Myeloma
Costs and Cost Analysis
Survival
Hispanic Americans

Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia

Kumar, V., Ailawadhi, S., Bojanini, L., Mehta, A., Biswas, S., Sher, T., Roy, V., Vishnu, P., Marin-Acevedo, J., Alegria, V. R., Paulus, A., Aulakh, S., Iqbal, M., Manochakian, R., Tan, W., Chanan-Khan, A. & Ailawadhi, M., Oct 1 2019, In : Blood cancer journal. 9, 10, 75.

Research output: Contribution to journalArticle

Open Access
Second Primary Neoplasms
B-Cell Chronic Lymphocytic Leukemia
Survivors
Incidence
Survival Rate
1 Citation (Scopus)

Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma

Kumar, V., Garg, M., Chandra, A. B., Mayorga, V. S., Ahmed, S. & Ailawadhi, S., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Second Primary Neoplasms
Hodgkin Disease
Neoplasms
Confidence Intervals
Incidence
13 Citations (Scopus)

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement

Gonsalves, W., Buadi, F. K., Ailawadhi, S., Bergsagel, P. L., Chanan Khan, A. A., Dingli, D. M., Dispenzieri, A., Fonseca, R., Hayman, S. R., Kapoor, P., Kourelis, T., Lacy, M., Larsen, J. T., Muchtar, E., Reeder, C. B., Sher, T., Stewart, A. K., Warsame, R., Go, R. S., Kyle, R. A. & 14 others, Leung, N., Lin, Y., Lust, J. A., Russell, S. J., Zeldenrust, S. R., Fonder, A. L., Hwa, Y. L., Hobbs, M. A., Mayo, A. A., Hogan, W., Rajkumar, S. V., Kumar, S. K., Gertz, M. & Roy, V., Jul 9 2018, (Accepted/In press) In : Bone Marrow Transplantation. p. 1-15 15 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Transplantation
Multiple Myeloma
Stem Cells
Transplants
Therapeutics
7 Citations (Scopus)

Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups

Ailawadhi, S., Swaika, A., Razavi, P., Yang, D. & Chanan Khan, A. A., Jan 1 2014, In : Blood Cancer Journal. 4, 9, e243.

Research output: Contribution to journalArticle

Second Primary Neoplasms
Multiple Myeloma
Incidence
Epidemiology
Survival
11 Citations (Scopus)
Waldenstrom Macroglobulinemia
Up-Regulation
Mutation
Therapeutics
Phosphatidylinositol 3-Kinases